Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DPP7 | Q9UHL4 | 2/20 | 0.38 |
| ▸ | CA1 | P00915 | 2/20 | 0.35 |
| ▸ | EPHX1 | P07099 | 8/20 | 0.35 |
| ▸ | GNAI3 | P08754 | 1/20 | 0.33 |
| ▸ | GNAO1 | P09471 | 1/20 | 0.33 |
| ▸ | GNAI1 | P63096 | 1/20 | 0.33 |
| ▸ | SIRT6 | Q8N6T7 | 1/20 | 0.33 |
| ▸ | SIRT1 | Q96EB6 | 1/20 | 0.33 |
| ▸ | ZDHHC20 | Q5W0Z9 | 1/20 | 0.33 |
| ▸ | ZDHHC2 | Q9UIJ5 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.32 |
| ▸ | RRM1 | P23921 | 1/20 | 0.32 |
| ▸ | ZDHHC7 | Q9NXF8 | 1/20 | 0.31 |
| ▸ | PAOX | Q6QHF9 | 1/20 | 0.31 |
| ▸ | CASP2 | P42575 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1285149 | 0.81 | — | — | |
| SCHEMBL20334483 | 0.81 | EPHX1 (0.40) | DPP7CA1EPHX1GNAI3GNAO1 | |
| SCHEMBL18574047 | 0.81 | EPHX1 (0.42) | DPP7CA1EPHX1ZDHHC20ZDHHC2 | |
| SCHEMBL29300329 | 0.80 | CNR1 (0.39) | DPP7CA1EPHX1SMN1; SMN2 | |
| SCHEMBL19143529 | 0.80 | KDM4E (0.33) | EPHX1 | |
| SCHEMBL25797415 | 0.80 | KDM4E (0.33) | EPHX1 | |
| SCHEMBL1286222 | 0.79 | CA1 (0.52) | CA1 | |
| SCHEMBL23221257 | 0.77 | CA1 (0.38) | DPP7CA1 | |
| SCHEMBL9198238 | 0.77 | CA1 (0.50) | CA1 | |
| SCHEMBL11227926 | 0.77 | CA1 (0.50) | CA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3562500-B1 | COMPOSITIONS IN THE FORM OF AN INJECTABLE AQUEOUS SOLUTION COMPRISING AMYLIN, AN AMYLIN RECEPTOR AGONIST OR AN AMYLIN ANALOGUE AND A COPOLYAMINO ACID | ADOCIA (FR) | 2023-07-19 | — | — | EP | disclosed |